Details for Patent: 12,077,533
✉ Email this page to a colleague
Which drugs does patent 12,077,533 protect, and when does it expire?
Patent 12,077,533 protects LITFULO and is included in one NDA.
This patent has sixty-eight patent family members in forty-five countries.
Drugs Protected by US Patent 12,077,533
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | LITFULO | ritlecitinib tosylate | CAPSULE;ORAL | 215830-001 | Jun 23, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | METHOD OF TREATING SEVERE ALOPECIA AREATA IN ADULTS AND ADOLESCENTS 12 YEARS AND OLDER BY ADMINISTERING RITLECTINIB | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,077,533
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3077395 | ⤷ Subscribe | 301245 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3077395 | ⤷ Subscribe | CA 2023 00028 | Denmark | ⤷ Subscribe |
| European Patent Office | 3077395 | ⤷ Subscribe | LUC00322 | Luxembourg | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
